Filing Details
- Accession Number:
- 0001127602-23-024448
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-19 17:05:52
- Reporting Period:
- 2023-09-18
- Accepted Time:
- 2023-09-19 17:05:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1496687 | Alec Machiels | C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-09-18 | 1,250 | $2.67 | 368,670 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-09-18 | 1,250 | $45.00 | 367,420 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-09-18 | 1,250 | $0.00 | 1,250 | $2.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2023-12-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 250,000 | Indirect | Indirect Owner (Bauhaus 1 LLC) |
Common Stock | 11,950 | Indirect | Indirect Owner (Owned by Spouse) |
Common Stock | 150,000 | Indirect | Indirect Owner (Spouse Trust) |
Footnotes
- This is a scheduled exercise and sale from 10B5-1 trading plan.
- The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
- Owned by spouse.
- On September 7, 2021, the reporting person's spouse transferred 150,000 shares of Apellis Pharmaceuticals, Inc. common stock to her trust, of which the reporting person is the trustee.
- This option was granted on December 5, 2013 and fully vested.